Oakes Gregory 4
4 · Landos Biopharma, Inc. · Filed Jun 22, 2022
Insider Transaction Report
Form 4
Oakes Gregory
DirectorChief Executive Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-06-20+1,677,251→ 1,677,251 totalExercise: $0.79Exp: 2032-06-19→ Common Stock (1,677,251 underlying)
Footnotes (1)
- [F1]25% of the shares of common stock underlying this option will vest and become exercisable on June 20, 2023 and the remaining shares of common stock underlying this option will vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date.